Zhigang Li

Summary

Publications

  1. pmc FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia
    Shu Guang Liu
    Hematology Oncology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Beijing Children s Hospital, Capital Medical University, 56 Nanlishi Road, 100045 Beijing, China
    Cancer Cell Int 13:107. 2013
  2. ncbi request reprint [Variant fusion transcript in ALL children with E2A-PBX1 fusion gene positive]
    Zhi Gang Li
    Hematological Center, Beijing Children Hospital Affiliated to Capital University of Medical Sciences, Beijing 100045, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:516-20. 2006
  3. ncbi request reprint [Clinical research on clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia]
    Zhi gang Yi
    Hematology Center, Beijing Children s Hospital Affiliated to Capital Medical University, Beijing 100045, China
    Zhonghua Er Ke Za Zhi 49:170-4. 2011
  4. doi request reprint DNMT3A mutations and prognostic significance in childhood acute lymphoblastic leukemia
    Weijing Li
    Beijing Key Laboratory of Pediatric Hematology Oncology National Key Discipline of Pediatrics, Ministry of Education Key Laboratory of Major Diseases in Children, Ministry of Education Hematology Oncology Center, Beijing Children s Hospital, Capital Medical University, Beijing, China
    Leuk Lymphoma 56:1066-71. 2015
  5. doi request reprint CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia
    Ying Jiao
    Key Laboratory of Major Diseases in Children, Ministry of Education and National Key Discipline of Pediatrics, Ministry of Education and Department of Hematology, Beijing Children s Hospital, Capital Medical University, 56 Nanlishi Road, Beijing, China
    Leuk Res 36:67-71. 2012
  6. pmc Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia
    Limin Zou
    Hematology Oncology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Beijing Children s Hospital, Capital Medical University, 56 Nanlishi Road, Beijing 100045, China
    J Hematol Oncol 5:42. 2012
  7. pmc Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
    Yanyan Mei
    Key Laboratory of Major Diseases in Children Capital Medical University, Ministry of Education, National Key Discipline of Pediatrics, Ministry of Education, Hematology Center, Beijing Children s Hospital, Capital Medical University, Beijing, China
    Cancer Sci 105:463-72. 2014
  8. doi request reprint miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia
    Xiao Liu
    Hematology Oncology Center, Beijing Children s Hospital, Capital Medical University, Beijing, China
    Leuk Res 36:1098-104. 2012
  9. doi request reprint Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia
    Lei Cui
    Hematological Center, Beijing Children s Hospital Affiliated to Capital Medical University, 56 Nanlishi Road, Beijing 100045, China
    Leuk Res 34:1314-9. 2010

Collaborators

  • Guoren Deng
  • Limin Zou
  • Wei Zhang
  • Shanshan Zhu
  • Huyong Zheng
  • Chao Gao
  • Lei Cui
  • Weijing Li
  • Xiaoxi Zhao
  • Minyuan Wu
  • Ying Jiao
  • Yanyan Mei
  • Shuguang Liu
  • Shu Guang Liu
  • Rui dong Zhang
  • Min Yuan Wu
  • Xiao Liu
  • Zhi gang Yi
  • Quangeng Zhang
  • Ruidong Zhang
  • Feifei Liu
  • Hongti Jia
  • Wei Ding
  • Kailing Wang
  • Zhen Ping Chen
  • Xiao Xi Zhao
  • Zhi Xia Yue
  • Wei Jing Li
  • Chaohao Du
  • Han Zhang
  • Lin Zhu
  • Shilai Bao
  • Mei Jin

Detail Information

Publications9

  1. pmc FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia
    Shu Guang Liu
    Hematology Oncology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Beijing Children s Hospital, Capital Medical University, 56 Nanlishi Road, 100045 Beijing, China
    Cancer Cell Int 13:107. 2013
    ..The aim of the present study was to investigate the impact of rs1544105 polymorphism on the treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL)...
  2. ncbi request reprint [Variant fusion transcript in ALL children with E2A-PBX1 fusion gene positive]
    Zhi Gang Li
    Hematological Center, Beijing Children Hospital Affiliated to Capital University of Medical Sciences, Beijing 100045, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 14:516-20. 2006
    ..The loss of 53aa would lead to the partial deletion of the putative loop-helix (LH) structure as well as the complete deletion of the heptad leucine repeat...
  3. ncbi request reprint [Clinical research on clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia]
    Zhi gang Yi
    Hematology Center, Beijing Children s Hospital Affiliated to Capital Medical University, Beijing 100045, China
    Zhonghua Er Ke Za Zhi 49:170-4. 2011
    ..To investigate the clinical value of clearance of leukemic cell during induction of remission therapy in children with precursor B cell acute lymphoblastic leukemia (BCP-ALL), and to assess the applicative value of different indexes...
  4. doi request reprint DNMT3A mutations and prognostic significance in childhood acute lymphoblastic leukemia
    Weijing Li
    Beijing Key Laboratory of Pediatric Hematology Oncology National Key Discipline of Pediatrics, Ministry of Education Key Laboratory of Major Diseases in Children, Ministry of Education Hematology Oncology Center, Beijing Children s Hospital, Capital Medical University, Beijing, China
    Leuk Lymphoma 56:1066-71. 2015
    ..078). Treatment outcome was obviously worse in patients with DNMT3A mutations than in other patients (p < 0.05). Thus, DNMT3A mutations can be found in a few children with ALL, and may have an adverse impact on prognosis. ..
  5. doi request reprint CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia
    Ying Jiao
    Key Laboratory of Major Diseases in Children, Ministry of Education and National Key Discipline of Pediatrics, Ministry of Education and Department of Hematology, Beijing Children s Hospital, Capital Medical University, 56 Nanlishi Road, Beijing, China
    Leuk Res 36:67-71. 2012
    ..We also developed an algorithm comprised of clinical risk and CASP8AP2 expression, which could predict bone marrow relapse more accurately...
  6. pmc Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia
    Limin Zou
    Hematology Oncology Center, Beijing Key Laboratory of Pediatric Hematology Oncology, National Key Discipline of Pediatrics, Beijing Children s Hospital, Capital Medical University, 56 Nanlishi Road, Beijing 100045, China
    J Hematol Oncol 5:42. 2012
    ..Our previous study indicated that SRSF1 can be methylated by protein arginine methyltransferase 1 (PRMT1) in vitro; however, the biological function of SRSF1 and PRMT1 in pediatric ALL are presently unknown...
  7. pmc Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia
    Yanyan Mei
    Key Laboratory of Major Diseases in Children Capital Medical University, Ministry of Education, National Key Discipline of Pediatrics, Ministry of Education, Hematology Center, Beijing Children s Hospital, Capital Medical University, Beijing, China
    Cancer Sci 105:463-72. 2014
    ..In conclusion, miR-210 may be a good prognostic factor and a useful predictor of drug sensitivity, and is a potential therapeutic target for pediatric ALL...
  8. doi request reprint miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia
    Xiao Liu
    Hematology Oncology Center, Beijing Children s Hospital, Capital Medical University, Beijing, China
    Leuk Res 36:1098-104. 2012
    ..Altogether these data demonstrate that the misregulation of hsa-miR-101 contributes partly to the overexpression of p23 in childhood ALL. As an anti-apoptotic factor, p23 is able to be a potential target for anti-leukemic therapy...
  9. doi request reprint Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia
    Lei Cui
    Hematological Center, Beijing Children s Hospital Affiliated to Capital Medical University, 56 Nanlishi Road, Beijing 100045, China
    Leuk Res 34:1314-9. 2010
    ....